Colgate-Palmolive (NYSE:CL) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC lowered its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 1.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 200,274 shares of the company’s stock after selling 2,282 shares during the period. Yousif Capital Management LLC’s holdings in Colgate-Palmolive were worth $18,207,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. FMR LLC raised its position in Colgate-Palmolive by 65.6% in the third quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after purchasing an additional 2,674,807 shares during the period. Barclays PLC raised its holdings in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares during the period. State Street Corp raised its holdings in shares of Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after buying an additional 1,784,411 shares during the period. Nordea Investment Management AB raised its holdings in shares of Colgate-Palmolive by 32.5% in the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock valued at $462,121,000 after buying an additional 1,247,731 shares during the period. Finally, Jacobs Levy Equity Management Inc. raised its holdings in shares of Colgate-Palmolive by 864.1% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 777,854 shares of the company’s stock valued at $80,749,000 after buying an additional 697,168 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Stifel Nicolaus cut their price target on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday. UBS Group cut their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. TD Cowen lowered their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $101.16.

Check Out Our Latest Analysis on CL

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $86.56 on Wednesday. The company has a market cap of $70.72 billion, a price-to-earnings ratio of 24.59, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44. The stock has a 50 day simple moving average of $91.19 and a 200-day simple moving average of $97.07. Colgate-Palmolive has a 12-month low of $82.68 and a 12-month high of $109.30. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive (NYSE:CLGet Free Report) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the prior year, the business posted $0.87 earnings per share. On average, equities analysts forecast that Colgate-Palmolive will post 3.74 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s payout ratio is currently 56.82%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Articles

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.